statement ended 30th Sept ended 30th Sept July - Sept 2020 July - Sept 2019 Change % Change Apr - Sept 2020 Apr - Sept 2019 Change % Change Revenue from sales & service 518.91 745.69 -226.78 -30.4% 930.49

controlled the selling and administrative expenses for more efficiency. For the period of 1st half ended 30th Sept 2019, the Company and its subsidiaries reported operating profit of Baht 78.45 million, a

Company”) would like to clarify the operating result of the financial statements as follows: Quarter 1 / year 2019 Quarter 1 / year 2020 Change Million Baht % Million Baht % Million Baht % Sales revenue

quarter of the year 2020, as at 30 June 2020, TCJ and its subsidiaries had the total revenue of Baht 568.38 million increased from Baht 543.85 million in the year 2019 or increased by 4.51%. Revenue

manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international standards ISO 9001:2008, GMP, PICS, HACCP และ HALAL. Presently, At-Ze

located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international

31 March 2020 in comparison with the corresponding period last year ended 31 March 2019 1 Revenue from sales Total revenue from sales were THB 4,061 million, an increase of THB 700 million or 20.8

its subsidiaries as details below: (Unit: Baht millions) For the period of three months Consolidated financial statement ended 30th June Apr 2019 - June 2019 Apr 2018 - June 2018 Change % Change Revenue

2019 Change % Change Revenue from sales & service 411.58 719.81 -308.23 -42.8% Other income 5.01 5.57 -0.56 -10.1% Total revenue 416.59 725.38 -308.79 -42.6% Cost of goods sold & service 383.13 638.35

Pursuant to Section 6(3) and Section 8(1) of the Royal Decree No. 750 issued by the Revenue Department, any VC or PE Trust wishing to receive revenue tax exemption is required to notify its VC or PE